№ files_lp_3_process_7_090459
File format: docx Character count: 9308 File size: 950 KB
Year: 2021
Region / City: India
Topic: Acute diarrhea, antimicrobial treatment
Document Type: Research Article
Author: Not specified
Target Audience: Medical professionals, researchers in infectious diseases
Duration: 5 days of treatment
Approval Date: Not specified
Modification Date: Not specified
Keywords: Acute diarrhea, fixed dose combination, metronidazole, mixed gastrointestinal infection, rifaximin
Context: A clinical study evaluating the efficacy and safety of a fixed-dose combination of rifaximin and metronidazole for treating acute diarrhea.
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Patient Group Direction (PGD) for the Supply of Oral Metronidazole for the Treatment of Bacterial Vaginosis (BV) or Trichomonas Vaginalis (TV)
Note: Version Number 2.1, October 2023
Year: 2023
Region / city: Not specified
Topic: Sexual Health, Bacterial Vaginosis, Trichomonas Vaginalis
Document Type: PGD (Patient Group Direction)
Organization: British Association for Sexual Health and HIV (BASHH)
Author: Ali Grant, Alison Crompton, Andrea Smith, and others
Target Audience: Registered healthcare professionals authorized to practice under PGDs
Effective Date: July 2023
Review Date: December 2025
Expiration Date: June 2026
Date of Approval: February 2023
Date of Last Change: October 2023
Rifaximin 24 month predicted versus actual utilisation analysis for hepatic encephalopathy following PBS listing
Year: 2016
Region / city: Australia
Topic: Pharmaceutical utilisation / hepatic encephalopathy
Document type: Analytical report
Organization / institution: Drug Utilisation Sub-Committee (DUSC), Department of Human Services (DHS)
Author: DUSC
Target audience: Healthcare policymakers, clinicians
Period covered: December 2013 – March 2016
Date of listing: 1 December 2013
Drug: Rifaximin
Indication: Prevention of hepatic encephalopathy recurrence
Dosage: 550 mg twice daily
Treatment requirements: Combination with lactulose if tolerated; prior episodes of HE required
Regulatory authority: Therapeutic Goods Administration (TGA)
PBS restriction: Specialist treatment only; telephone authority approval required
Study type: Retrospective utilisation analysis
Key findings: Patient numbers higher than predicted; prescriptions per patient lower than estimated; expenditure aligned with second-year projections
Shared Care Refusal Letter for Rifaximin (Targaxan) in Hepatic Encephalopathy
Year: 2018
Region / City: Kent and Medway, UK
Topic: Hepatic Encephalopathy treatment
Document Type: Letter
Organization / Institution: NHS Kent and Medway
Author: Primary Care Prescriber
Target Audience: Specialist prescriber
Medication: Rifaximin (Targaxan)
Shared Care Protocol Reference: NHS Kent and Medway shared care protocol
Reason for Refusal: Lack of clinical confidence, protocol not received, patient not optimised, minimum supply not met, medicine not suitable for shared care, other clinical reasons
Patient Information Included: Name, NHS Number, Date of Birth/Address
Date of Document: [insert date]
Food Establishment Vomiting and Diarrhea Cleanup Plan
Year: 2021
Region / City: Seattle, King County
Topic: Food safety, cleaning protocols
Document Type: Guidelines
Organization / Institution: Public Health Seattle & King County
Author: Public Health Seattle & King County
Target Audience: Food establishments, food employees
Period of Validity: Ongoing
Approval Date: Not specified
Date of Modifications: Not specified
AMC Toolkit: Vomit and Diarrhea Clean-up Plan
Note: Year
Topic: Food safety, sanitation
Document Type: Procedure
Target Audience: Food establishment employees
Plan Review Frequency: Annual
Maryland Next Gen NCLEX Test Bank Project: Pediatric Diarrhea and Dehydration Case Study (September 1, 2022)
Year: 2022
Date: September 1, 2022
Project Title: Maryland Next Gen NCLEX Test Bank Project
Case Study Topic: Pediatric diarrhea and dehydration
Author: Mary Tiso RN, MS, CNL
Institution: Community College of Baltimore County
Document Type: Educational case study with assessment questions and scoring rationale
Clinical Setting: Outpatient pediatric ambulatory clinic
Patient Profile: 2-year-old male with diarrhea and moderate dehydration
Subject Area: Pediatric nursing; fluid and electrolyte imbalance
Includes: Case summary, objectives, nurse’s notes, vital signs, assessment tasks, plan of care decisions, scoring rules, rationales, references, QR codes, and external links
References Cited: Ricci, Kyle, Carman (2020); Canavan and Arant (2009)
Vomit and Diarrhea Clean-up Plan Toolkit (DOH 333-285, December 2022)
Title: Vomit and Diarrhea Clean-up Plan Toolkit
Document Code: DOH 333-285
Publication Date: December 2022
Jurisdiction: Washington State
Regulatory Reference: WAC 246-215-02500
Issuing Authority: Washington State Department of Health
Subject: Sanitation and contamination control in food establishments
Document Type: Regulatory compliance toolkit and clean-up plan template
Applicable Facilities: Food establishments
Required Plan Status: Written clean-up plan required on site
Training Requirement: Employee training required prior to implementation
Review Requirement: Plan available for review by regulatory authority
Plan Review Frequency: Annually or as updated by establishment
Contact Information: 1-800-525-0127; 711 (Washington Relay); [email protected]
I'm vomiting I have a rash or skin infection I have diarrhea I have an eye infection I have a bad cough or sore throat I'm just not feeling very good I have a fever Keep me home if . . .
Note: Year
Context description: A document with a list of symptoms and conditions related to health that require a child to stay at home from daycare, presented as a form for daycare enrollment.
Topics: Metronidazole Rifaximin Diarrhea